Exact Mass: 495.4651196

Exact Mass Matches: 495.4651196

Found 140 metabolites which its exact mass value is equals to given mass value 495.4651196, within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error 0.01 dalton.

(14Z)-Tricos-14-enoylcarnitine

3-(tricos-14-enoyloxy)-4-(trimethylazaniumyl)butanoate

C30H57NO4 (495.42873620000006)


(14Z)-Tricos-14-enoylcarnitine is an acylcarnitine. More specifically, it is an (14Z)-tricos-14-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (14Z)-Tricos-14-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (14Z)-Tricos-14-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(18Z)-Tricos-18-enoylcarnitine

3-(tricos-18-enoyloxy)-4-(trimethylazaniumyl)butanoate

C30H57NO4 (495.42873620000006)


(18Z)-Tricos-18-enoylcarnitine is an acylcarnitine. More specifically, it is an (18Z)-tricos-18-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (18Z)-Tricos-18-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (18Z)-Tricos-18-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(17Z)-Tricos-17-enoylcarnitine

3-(tricos-17-enoyloxy)-4-(trimethylazaniumyl)butanoate

C30H57NO4 (495.42873620000006)


(17Z)-Tricos-17-enoylcarnitine is an acylcarnitine. More specifically, it is an (17Z)-tricos-17-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (17Z)-Tricos-17-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (17Z)-Tricos-17-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

(9Z)-Tricos-9-enoylcarnitine

3-(tricos-9-enoyloxy)-4-(trimethylazaniumyl)butanoate

C30H57NO4 (495.42873620000006)


(9Z)-Tricos-9-enoylcarnitine is an acylcarnitine. More specifically, it is an (9Z)-tricos-9-enoic acid ester of carnitine. Acylcarnitines were first discovered more than 70 year ago (PMID: 13825279). It is believed that there are more than 1000 types of acylcarnitines in the human body. The general role of acylcarnitines is to transport acyl-groups (organic acids and fatty acids) from the cytoplasm into the mitochondria so that they can be broken down to produce energy. This process is known as beta-oxidation. According to a recent review [Dambrova et al. 2021, Physiological Reviews], acylcarnitines (ACs) can be classified into 9 different categories depending on the type and size of their acyl-group: 1) short-chain ACs; 2) medium-chain ACs; 3) long-chain ACs; 4) very long-chain ACs; 5) hydroxy ACs; 6) branched chain ACs; 7) unsaturated ACs; 8) dicarboxylic ACs and 9) miscellaneous ACs. Short-chain ACs have acyl-groups with two to five carbons (C2-C5), medium-chain ACs have acyl-groups with six to thirteen carbons (C6-C13), long-chain ACs have acyl-groups with fourteen to twenty once carbons (C14-C21) and very long-chain ACs have acyl groups with more than 22 carbons. (9Z)-Tricos-9-enoylcarnitine is therefore classified as a very-long chain AC. As a very long-chain acylcarnitine (9Z)-Tricos-9-enoylcarnitine is generally formed in the cytoplasm from very long acyl groups synthesized by fatty acid synthases or obtained from the diet. Very-long-chain fatty acids are generally too long to be involved in mitochondrial beta-oxidation. As a result peroxisomes are the main organelle where very-long-chain fatty acids are metabolized and their acylcarnitines synthesized (PMID: 18793625). Altered levels of very long-chain acylcarnitines can serve as useful markers for inherited disorders of peroxisomal metabolism. The study of acylcarnitines is an active area of research and it is likely that many novel acylcarnitines will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered. An excellent review of the current state of knowledge for acylcarnitines is available at [Dambrova et al. 2021, Physiological Reviews].

   

Cer 31:1;O2

N-(hexadecanoyl)-4E-pentadeca-sphingenine

C31H61NO3 (495.4651196)


   

N-(hexadecanoyl)-4E-pentadecasphingenine

N-(hexadecanoyl)-4E-pentadecasphingenine

C31H61NO3 (495.4651196)


   

N-(2-hydroxydodecanoyl)-sphinga-4,8-dienine

N-(2-hydroxydodecanoyl)-sphinga-4,8-dienine

C30H57NO4 (495.42873620000006)


   
   
   
   
   

32-Hydroxylacceroate

32-Hydroxylacceroate

C32H63O3- (495.4776948)


   

N-tetradecanoyl-15-methylhexadecasphing-4-enine

N-tetradecanoyl-15-methylhexadecasphing-4-enine

C31H61NO3 (495.4651196)


   

(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoate

(16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoate

C34H55O2- (495.42018299999995)


A polyunsaturated fatty acid anion that is the conjugate base of (16Z,19Z,22Z,25Z,28Z,31Z)-tetratriacontahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tricosanamide

N-[(E)-1,3-dihydroxyoct-4-en-2-yl]tricosanamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxynonan-2-yl)docos-13-enamide

(Z)-N-(1,3-dihydroxynonan-2-yl)docos-13-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]butanamide

N-[(E)-1,3-dihydroxyheptacos-4-en-2-yl]butanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]pentanamide

N-[(E)-1,3-dihydroxyhexacos-4-en-2-yl]pentanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxytricos-4-en-2-yl]octanamide

N-[(E)-1,3-dihydroxytricos-4-en-2-yl]octanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxynon-4-en-2-yl]docosanamide

N-[(E)-1,3-dihydroxynon-4-en-2-yl]docosanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyoctacos-4-en-2-yl]propanamide

N-[(E)-1,3-dihydroxyoctacos-4-en-2-yl]propanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxypentacos-4-en-2-yl]hexanamide

N-[(E)-1,3-dihydroxypentacos-4-en-2-yl]hexanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]heptanamide

N-[(E)-1,3-dihydroxytetracos-4-en-2-yl]heptanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxydocos-4-en-2-yl]nonanamide

N-[(E)-1,3-dihydroxydocos-4-en-2-yl]nonanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxynonacos-4-en-2-yl]acetamide

N-[(E)-1,3-dihydroxynonacos-4-en-2-yl]acetamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxydodecan-2-yl)nonadec-9-enamide

(Z)-N-(1,3-dihydroxydodecan-2-yl)nonadec-9-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxydec-4-en-2-yl]henicosanamide

N-[(E)-1,3-dihydroxydec-4-en-2-yl]henicosanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]decanamide

N-[(E)-1,3-dihydroxyhenicos-4-en-2-yl]decanamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)tridec-9-enamide

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)tridec-9-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]octadecanamide

N-[(E)-1,3-dihydroxytridec-4-en-2-yl]octadecanamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxytridecan-2-yl)octadec-9-enamide

(Z)-N-(1,3-dihydroxytridecan-2-yl)octadec-9-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]icosanamide

N-[(E)-1,3-dihydroxyundec-4-en-2-yl]icosanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]undecanamide

N-[(E)-1,3-dihydroxyicos-4-en-2-yl]undecanamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexadec-9-enamide

(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexadec-9-enamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxydecan-2-yl)henicos-11-enamide

(Z)-N-(1,3-dihydroxydecan-2-yl)henicos-11-enamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxytetradecan-2-yl)heptadec-9-enamide

(Z)-N-(1,3-dihydroxytetradecan-2-yl)heptadec-9-enamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxyundecan-2-yl)icos-11-enamide

(Z)-N-(1,3-dihydroxyundecan-2-yl)icos-11-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]nonadecanamide

N-[(E)-1,3-dihydroxydodec-4-en-2-yl]nonadecanamide

C31H61NO3 (495.4651196)


   
   
   

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tetradec-9-enamide

(Z)-N-(1,3-dihydroxyheptadecan-2-yl)tetradec-9-enamide

C31H61NO3 (495.4651196)


   

N-[(8E,12E)-1,3,4-trihydroxypentadeca-8,12-dien-2-yl]pentadecanamide

N-[(8E,12E)-1,3,4-trihydroxypentadeca-8,12-dien-2-yl]pentadecanamide

C30H57NO4 (495.42873620000006)


   

(Z)-N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]dodec-5-enamide

(Z)-N-[(E)-1,3,4-trihydroxyoctadec-8-en-2-yl]dodec-5-enamide

C30H57NO4 (495.42873620000006)


   

N-[(8E,12E)-1,3,4-trihydroxyheptadeca-8,12-dien-2-yl]tridecanamide

N-[(8E,12E)-1,3,4-trihydroxyheptadeca-8,12-dien-2-yl]tridecanamide

C30H57NO4 (495.42873620000006)


   

(Z)-N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]hexadec-7-enamide

(Z)-N-[(E)-1,3,4-trihydroxytetradec-8-en-2-yl]hexadec-7-enamide

C30H57NO4 (495.42873620000006)


   

(Z)-N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]pentadec-9-enamide

(Z)-N-[(E)-1,3,4-trihydroxypentadec-8-en-2-yl]pentadec-9-enamide

C30H57NO4 (495.42873620000006)


   

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]hexadecanamide

N-[(E)-1,3-dihydroxypentadec-4-en-2-yl]hexadecanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]tridecanamide

N-[(E)-1,3-dihydroxyoctadec-4-en-2-yl]tridecanamide

C31H61NO3 (495.4651196)


   

(Z)-N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tridec-8-enamide

(Z)-N-[(E)-1,3,4-trihydroxyheptadec-8-en-2-yl]tridec-8-enamide

C30H57NO4 (495.42873620000006)


   

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]dodecanamide

N-[(E)-1,3-dihydroxynonadec-4-en-2-yl]dodecanamide

C31H61NO3 (495.4651196)


   

(4Z,7Z)-N-(1,3,4-trihydroxytetradecan-2-yl)hexadeca-4,7-dienamide

(4Z,7Z)-N-(1,3,4-trihydroxytetradecan-2-yl)hexadeca-4,7-dienamide

C30H57NO4 (495.42873620000006)


   

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]heptadecanamide

N-[(E)-1,3-dihydroxytetradec-4-en-2-yl]heptadecanamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]pentadecanamide

N-[(E)-1,3-dihydroxyhexadec-4-en-2-yl]pentadecanamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxyhexadecan-2-yl)pentadec-9-enamide

(Z)-N-(1,3-dihydroxyhexadecan-2-yl)pentadec-9-enamide

C31H61NO3 (495.4651196)


   

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]tetradecanamide

N-[(E)-1,3-dihydroxyheptadec-4-en-2-yl]tetradecanamide

C31H61NO3 (495.4651196)


   

N-[(8E,12E)-1,3,4-trihydroxyhexadeca-8,12-dien-2-yl]tetradecanamide

N-[(8E,12E)-1,3,4-trihydroxyhexadeca-8,12-dien-2-yl]tetradecanamide

C30H57NO4 (495.42873620000006)


   

N-[(8E,12E)-1,3,4-trihydroxyoctadeca-8,12-dien-2-yl]dodecanamide

N-[(8E,12E)-1,3,4-trihydroxyoctadeca-8,12-dien-2-yl]dodecanamide

C30H57NO4 (495.42873620000006)


   

N-[(8E,12E)-1,3,4-trihydroxytetradeca-8,12-dien-2-yl]hexadecanamide

N-[(8E,12E)-1,3,4-trihydroxytetradeca-8,12-dien-2-yl]hexadecanamide

C30H57NO4 (495.42873620000006)


   

(Z)-N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tetradec-9-enamide

(Z)-N-[(E)-1,3,4-trihydroxyhexadec-8-en-2-yl]tetradec-9-enamide

C30H57NO4 (495.42873620000006)


   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   
   

(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexadec-7-enamide

(Z)-N-(1,3-dihydroxypentadecan-2-yl)hexadec-7-enamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)tridec-8-enamide

(Z)-N-(1,3-dihydroxyoctadecan-2-yl)tridec-8-enamide

C31H61NO3 (495.4651196)


   

(Z)-N-(1,3-dihydroxynonadecan-2-yl)dodec-5-enamide

(Z)-N-(1,3-dihydroxynonadecan-2-yl)dodec-5-enamide

C31H61NO3 (495.4651196)


   

N-(tridecanoyl)-4E-sphingenine

N-(tridecanoyl)-4E-sphingenine

C31H61NO3 (495.4651196)


   

N-(decanoyl)-4E-heneicosasphingenine

N-(decanoyl)-4E-heneicosasphingenine

C31H61NO3 (495.4651196)


   

N-(dodecanoyl)-4E-nonadecasphingenine

N-(dodecanoyl)-4E-nonadecasphingenine

C31H61NO3 (495.4651196)


   

N-(heptadecanoyl)-4E-tetradecasphingenine

N-(heptadecanoyl)-4E-tetradecasphingenine

C31H61NO3 (495.4651196)


   

N-(pentadecanoyl)-4E-hexadecasphingenine

N-(pentadecanoyl)-4E-hexadecasphingenine

C31H61NO3 (495.4651196)


   

N-(tetradecanoyl)-4E-heptadecasphingenine

N-(tetradecanoyl)-4E-heptadecasphingenine

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]tridecanamide

N-[(E,2S,3R)-1,3-dihydroxyoctadec-8-en-2-yl]tridecanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxytetradec-8-en-2-yl]heptadecanamide

N-[(E,2S,3R)-1,3-dihydroxytetradec-8-en-2-yl]heptadecanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]pentadecanamide

N-[(E,2S,3R)-1,3-dihydroxyhexadec-8-en-2-yl]pentadecanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxyhenicos-8-en-2-yl]decanamide

N-[(E,2S,3R)-1,3-dihydroxyhenicos-8-en-2-yl]decanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxyheptadec-8-en-2-yl]tetradecanamide

N-[(E,2S,3R)-1,3-dihydroxyheptadec-8-en-2-yl]tetradecanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxynonadec-8-en-2-yl]dodecanamide

N-[(E,2S,3R)-1,3-dihydroxynonadec-8-en-2-yl]dodecanamide

C31H61NO3 (495.4651196)


   

N-[(E,2S,3R)-1,3-dihydroxypentadec-8-en-2-yl]hexadecanamide

N-[(E,2S,3R)-1,3-dihydroxypentadec-8-en-2-yl]hexadecanamide

C31H61NO3 (495.4651196)


   

(E)-N-[(2S,3R)-1,3-dihydroxypentadecan-2-yl]hexadec-9-enamide

(E)-N-[(2S,3R)-1,3-dihydroxypentadecan-2-yl]hexadec-9-enamide

C31H61NO3 (495.4651196)


   

(E)-N-[(2S,3R)-1,3-dihydroxytetradecan-2-yl]heptadec-9-enamide

(E)-N-[(2S,3R)-1,3-dihydroxytetradecan-2-yl]heptadec-9-enamide

C31H61NO3 (495.4651196)


   

omega-hydroxydotriacontanoate(1-)

omega-hydroxydotriacontanoate(1-)

C32H63O3 (495.4776948)


A hydroxy fatty acid anion that is the conjugate base of omega-hydroxydotriacontanoic acid, obtained by deprotonation of the carboxy group.

   

tetratriacontahexaenoate

tetratriacontahexaenoate

C34H55O2 (495.42018299999995)


A polyunsaturated fatty acid anion that is the conjugate base of tetratriacontahexaenoic acid, obtained by deprotonation of the carboxy group; major species at pH 7.3.

   

AcCa(23:1)

AcCa(23:1)

C30H57NO4 (495.42873620000006)


Provides by LipidSearch Vendor. © Copyright 2006-2024 Thermo Fisher Scientific Inc. All rights reserved